Declare identity and patent status of pharmaceutical product under Canada's Access to Medicines Regime

The pharmaceutical company must complete and submit to the Commissioner of Patents one of the forms listed below. The company should choose the form that corresponds to the schedule on which the importing country appears, as well as the patent status of the pharmaceutical product in that country.

Data and Resources

Additional Info

Field Value
Last Updated April 17, 2026, 21:54 (UTC)
Created April 17, 2026, 21:54 (UTC)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2017-04-28 00:00:00
open_canada_keywords {"fr": ["Régime canadien d'accès aux médicaments", "déclaration de l'identité et de l'état du brevet du produit pharmaceutique", "entreprise pharmaceutique", "commissaire aux brevets"], "en": ["Canada's Access to Medicines Regime", "declare identity and patent status of pharmaceutical product", "pharmaceutical company", "Commissioner of Patents."]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr Déclaration de l'identité et de l'état du brevet du produit pharmaceutique : Régime canadien d'accès aux médicaments
update_frequency as_needed